September 3, 2025

Dad’s childhood passive smoking may confer lifelong poor lung health onto his kids

September 3, 2025 / Lung health, Patient education / InnovateMed Author / passive smoking

by the British Medical Journal edited by Sadie Harley, reviewed by Robert Egan Credit: Pixabay/CC0 Public Domain A father’s exposure to passive smoking as a child may impair the lifelong lung function of his children, putting them at risk of COPD—a risk that is heightened further if they are childhood passive smokers themselves, finds research published online […]

Dad’s childhood passive smoking may confer lifelong poor lung health onto his kids Read More »

Happy music could help you recover from motion sickness

September 3, 2025 / Patient education / InnovateMed Author / motion sickness

by Frontiers edited by Gaby Clark, reviewed by Robert Egan Credit: Unsplash/CC0 Public Domain Scientists studying ways of improving motion sickness have found that playing different types of music may help people recover more effectively. Using a specially calibrated driving simulator, they induced car sickness in participants and then played different types of music while they tried to

Happy music could help you recover from motion sickness Read More »

How a Robot Performed Surgery Without Human Assistance – robotics

September 3, 2025 / Artificial Intelligence, Research update / InnovateMed Author / Robot Performed Surgery

How a Robot Performed Surgery Without Human Assistance Christina Szalinski August 28, 2025 The machines continue to rise. Researchers used artificial intelligence (AI) to train a robotic program to do parts of a gallbladder removal surgery, or a cholecystectomy. The robotic surgeon successfully performed its surgical tasks on eight pig cadavers, according to a new

How a Robot Performed Surgery Without Human Assistance – robotics Read More »

Beyond the trip: How compounds derived from psychedelics could help treat inflammatory conditions

September 3, 2025 / Research update / InnovateMed Author / inflammatory conditions, psychedelics

by University of Birmingham edited by Sadie Harley, reviewed by Robert Egan Anti-inflammatory actions of the psychedelic drug, psilocybin, in a clinical trial and impact of the active metabolite, psilocin, upon isolated cells in vitro. Credit: British Journal of Pharmacology (2025). DOI: 10.1111/bph.70138 Psychedelic drugs, long-known for their powerful effects on perception and emotion, may hold the key to

Beyond the trip: How compounds derived from psychedelics could help treat inflammatory conditions Read More »

Investigators create urine-based test to ID prostate cancers

September 3, 2025 / Cancer, Research update / InnovateMed Author / create urine-based test, prostate cancers

by Johns Hopkins University School of Medicine edited by Sadie Harley, reviewed by Andrew Zinin Discovery and identification of urine-enriched liquid biopsy biomarkers in PCa. Credit: eBioMedicine (2025). DOI: 10.1016/j.ebiom.2025.105895 Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children’s Hospital and four other institutions have devised a novel method to test for prostate cancer using biomarkers present

Investigators create urine-based test to ID prostate cancers Read More »

Customizable protein helps body remove harmful cells, offering hope for cancer and autoimmune diseases

September 3, 2025 / Research update / InnovateMed Author / autoimmune diseases

by Kyoto University edited by Stephanie Baum, reviewed by Robert Egan Crunch helps immune cells recognize and remove harmful cells by connecting them directly to specific targets, guiding the body’s natural clean-up process. Credit: Mindy Takamiya / Kyoto University iCeMS A team of scientists at Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS) has created a protein-based therapeutic

Customizable protein helps body remove harmful cells, offering hope for cancer and autoimmune diseases Read More »

New, ‘off-the-shelf’ immunotherapy shows promise for treating high-risk childhood leukemia

September 3, 2025 / Cancer, Immunology / InnovateMed Author / childhood leukemia, immunotherapy

by University of Oxford edited by Lisa Lock, reviewed by Andrew Zinin Credit: Blood Journal (2025). DOI: 10.1182/blood.. 2025029302 Scientists at the University of Oxford, together with colleagues at Imperial College London and the University of Glasgow, have developed a new type of immunotherapy that could improve outcomes for infants and children with high-risk leukemia. Acute lymphoblastic leukemia is

New, ‘off-the-shelf’ immunotherapy shows promise for treating high-risk childhood leukemia Read More »

Affordable, accessible, online pain management program developed

September 3, 2025 / Clinical Practice / InnovateMed Author / pain management

by University of Otago edited by Lisa Lock, reviewed by Andrew Zinin Credit: Pixabay/CC0 Public Domain Providing an online program to help those living with persistent pain could remove barriers to accessing help, a University of Otago—Ōtākou Whakaihu Waka-led study has found. Persistent pain is a leading cause of disability worldwide. In Aotearoa New Zealand, it affects more

Affordable, accessible, online pain management program developed Read More »

Shampoo-like gel could help chemo patients keep their hair

September 3, 2025 / Research update / InnovateMed Author / chemo patients, Shampoo-like gel

by Michigan State University edited by Sadie Harley, reviewed by Robert Egan Credit: Biomaterials Advances (2025). DOI: 10.1016/j.bioadv.2025.214452 Cancer fighters know that losing their hair is often part of the battle, but Michigan State University researchers have developed a shampoo-like gel that has been tested in animal models and could protect hair from falling out during chemotherapy treatment. Baldness from

Shampoo-like gel could help chemo patients keep their hair Read More »

Common arthritis drug found to lower blood pressure and risk of heart disease

September 3, 2025 / Arthritis, Cardiovascular health, Clinical Practice / InnovateMed Author / arthritis drug, blood pressure

by Flinders University edited by Lisa Lock, reviewed by Andrew Zinin Effects of methotrexate (Group 1) and sulfasalazine (Group 2) on systolic blood pressure using a repeated measures mixed effects model. Credit: Annals of Medicine (2025). DOI: 10.1080/07853890.2025.2539311 Methotrexate, a common medication used to treat rheumatoid arthritis, has a newly recognized useful secondary effect of lowering blood pressure and potentially

Common arthritis drug found to lower blood pressure and risk of heart disease Read More »